Clinical Trial: Biomarkers Usefulness in the Screening of Hepatocellular Carcinoma in an European High-risk Cohort.

U.S., Oct. 14 -- ClinicalTrials.gov registry received information related to the study (NCT07872319) titled 'Biomarkers Usefulness in the Screening of Hepatocellular Carcinoma in an European High-risk Cohort.' on Oct. 07.

Brief Summary: Longitudinal, prospective, observational, non-interventional study, to evaluate the performance of tumour biomarkers Alpha-fetoprotein (AFP), Lens culinaris-agglutinin-reactive fraction of AFP (AFP-L3), and protein induced by vitamin K absence or antagonist-II (PIVKA-II) and their combinations (GAAD and GALAD algorithms) in the screening of HCC.

Study Start Date: Feb. 02, 2022

Study Type: OBSERVATIONAL

Condition: Hepatocellular Carcinoma (HCC)

Recruitment Status: COMPLETED

Sponsor: Hospital Universita...